• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿扑吗啡在帕金森病中的药代动力学

Pharmacokinetics of apomorphine in Parkinson's disease.

作者信息

Gancher S

机构信息

Department of Neurology, Oregon Health Sciences University, Portland, USA.

出版信息

J Neural Transm Suppl. 1995;45:137-41.

PMID:8748619
Abstract

The pharmacokinetic properties of apomorphine in patients with Parkinson's disease are described. Apomorphine is lipophilic; it has a large volume of distribution and is rapidly cleared from plasma, with an elimination half life of 33 minutes. It is rapidly absorbed following subcutaneous injection, with peak levels achieved within 5-10 minutes in most patients. There is a large variation in absorption between patients but is more constant within patients following repeated dosing. Apomorphine rapidly equilibrates between plasma and brain. Like levodopa, the response tends to be largely "all or none"; larger doses produce a longer duration of effect within a 30-90 minute range. Apomorphine may be administered intranasally and sublingually; of these routes, the former is more quickly and completely absorbed. Other routes of administration, including rectally, are not as well absorbed but may also be used effectively.

摘要

描述了阿扑吗啡在帕金森病患者中的药代动力学特性。阿扑吗啡具有亲脂性;其分布容积大,能迅速从血浆中清除,消除半衰期为33分钟。皮下注射后吸收迅速,大多数患者在5 - 10分钟内达到峰值水平。患者之间的吸收差异很大,但重复给药后患者体内的吸收更稳定。阿扑吗啡在血浆和脑之间迅速达到平衡。与左旋多巴一样,反应往往在很大程度上是“全或无”的;较大剂量在30 - 90分钟范围内产生更长的作用持续时间。阿扑吗啡可经鼻内和舌下给药;在这些给药途径中,前者吸收更快、更完全。其他给药途径,包括直肠给药,吸收不太好,但也可有效使用。

相似文献

1
Pharmacokinetics of apomorphine in Parkinson's disease.阿扑吗啡在帕金森病中的药代动力学
J Neural Transm Suppl. 1995;45:137-41.
2
Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?舌下含服阿扑吗啡:帕金森病治疗的一种新药理学方法?
J Neural Transm Suppl. 1995;45:157-61.
3
Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease.
Clin Neuropharmacol. 1998 May-Jun;21(3):159-68.
4
Peripheral pharmacokinetics of apomorphine in humans.
Ann Neurol. 1989 Aug;26(2):232-8. doi: 10.1002/ana.410260209.
5
Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease.逐步静脉输注阿扑吗啡以确定帕金森病患者的治疗窗。
Clin Neuropharmacol. 1998 May-Jun;21(3):152-8.
6
A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.间歇性皮下注射阿扑吗啡用于晚期帕金森病运动波动急救处理的综述。
Clin Ther. 2005 Nov;27(11):1710-24. doi: 10.1016/j.clinthera.2005.11.016.
7
Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application.帕金森病患者经鼻内和皮下应用后阿扑吗啡的药代动力学
Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):27-33. doi: 10.1007/BF03192285.
8
Subcutaneously administered apomorphine: pharmacokinetics and metabolism.皮下注射阿扑吗啡:药代动力学与代谢
Neurology. 2004 Mar 23;62(6 Suppl 4):S8-11. doi: 10.1212/wnl.62.6_suppl_4.s8.
9
Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.帕金森病患者中阿扑吗啡的药代动力学-药效学关系。
Clin Pharmacokinet. 1999 Sep;37(3):257-71. doi: 10.2165/00003088-199937030-00004.
10
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories.
Mov Disord. 1995 Jul;10(4):433-9. doi: 10.1002/mds.870100405.

引用本文的文献

1
Deciphering Spinal Endogenous Dopaminergic Mechanisms That Modulate Micturition Reflexes in Rats with Spinal Cord Injury.解析脊髓内源性多巴胺能机制调节脊髓损伤大鼠排尿反射。
eNeuro. 2021 Jul 29;8(4). doi: 10.1523/ENEURO.0157-21.2021. Print 2021 Jul-Aug.
2
Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments.阿朴吗啡治疗意识障碍:采用多模态评估的双盲随机对照试验方案。
Front Neurol. 2019 Mar 19;10:248. doi: 10.3389/fneur.2019.00248. eCollection 2019.
3
Transdermal treatment options for neurological disorders: impact on the elderly.
神经系统疾病的经皮治疗选择:对老年人的影响。
Drugs Aging. 2006;23(5):357-75. doi: 10.2165/00002512-200623050-00001.
4
[Apomorphine in the treatment of Parkinson's Disease].[阿扑吗啡在帕金森病治疗中的应用]
Nervenarzt. 2005 Jun;76(6):681-9. doi: 10.1007/s00115-004-1830-4.
5
Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.皮下注射阿扑吗啡治疗晚期帕金森病:长期随访
J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):709-16. doi: 10.1136/jnnp.65.5.709.